cdmo.directory
← Compare landing

Quotient Sciences vs Sterling Pharma Solutions

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryQuotient SciencesSterling Pharma Solutions
SummaryIntegrated CDMO offering drug product formulation and manufacturing for small molecules and synthetic peptides, with 30+ years of experience and scalable capacity from clinical to 500 kg commercial batches across US and UK facilities.Small molecule CDMO offering comprehensive API development and manufacturing from discovery through commercial cGMP production, with specialized expertise in complex and hazardous chemistries and ADC bioconjugation.
Services
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Peptide Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Oral Solid Dosage Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Controlled Substance Manufacturing
  • Flow Chemistry & Continuous Manufacturing
  • Solid-State Chemistry & Polymorph Screening
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Bioconjugation Services
  • Peptide Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Peptide
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Peptide
Development capabilities
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Analytical method development
  • Solid-state characterization
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Oral Solid Dose (OSD)
  • Max chemical: Commercial (>100 kg / tonne)
  • HPAPI
  • Drug Substance (DS)
  • Max chemical: Commercial (>100 kg / tonne)
  • HPAPI
  • DEA licensed
  • Flow Chemistry
Locations
  • Headquarters, Nottingham, Nottinghamshire, UK
  • Clinical Pharmacology & Data Sciences, Miami, Florida, USA
  • Manufacturing & Formulation Development, Boothwyn, Pennsylvania, USA
  • Formulation Development & Clinical Trial Manufacturing, Garnet Valley, Pennsylvania, USA
  • Data Sciences Center, Edinburgh, Scotland, UK
  • Drug Substance Manufacturing (Arcinova), Alnwick, Northumberland, UK
  • Drug Substance Manufacturing & Bioanalysis, Alnwick, Northumberland, UK
  • Garnet Valley, Garnet Valley, Pennsylvania, United States
  • Boothwyn, Boothwyn, Pennsylvania, United States
  • Reading, Reading, England, United Kingdom
  • Miami, Miami, Florida, United States
  • Nottingham, Nottingham, England, United Kingdom
  • Cork, Cork, Munster, Ireland
  • Cramlington, Cramlington, Northumberland, United Kingdom
  • Deeside, Deeside, Wales, United Kingdom
  • Newcastle Biosphere, Newcastle, Tyne and Wear, United Kingdom
  • North Carolina, North Carolina, North Carolina, United States
  • Wisconsin, Wisconsin, Wisconsin, United States
  • North Carolina, North Carolina, North Carolina, US
  • Wisconsin, Wisconsin, Wisconsin, US
  • Newcastle Biosphere, Newcastle, England, UK
  • North Carolina, North Carolina, US
  • Wisconsin, Wisconsin, US
  • Cramlington, Cramlington, England, UK
  • North Carolina, North Carolina, North Carolina, USA
  • Wisconsin, Wisconsin, Wisconsin, USA
Certifications
  • FDA · Identifier: United States Food and Drug Administration
  • PMDA · Identifier: Japanese Pharmaceuticals & Medical Devices Agency
  • ANVISA · Identifier: Brazilian Health Regulatory Agency
  • NMPA · Identifier: Chinese National Medical Products Administration
  • FDA · Identifier: cGMP inspection
  • HPRA · Identifier: cGMP inspection (mutually recognised by FDA)
  • PMDA · Identifier: Project specific inspection
  • ANVISA · Identifier: Project specific inspection
  • MHRA · Identifier: cGMP inspection
  • DEA · Identifier: Schedule I-V controlled substances approval
  • ISO · Identifier: ISO/IEC 27001:2022, ISO/IEC 9001:2015, ISO 45001:2018, ISO 14001:2015
  • FDA · Identifier: cGMP inspection January 2017
  • PMDA · Identifier: project specific inspection June 2022
  • HPRA · Identifier: cGMP inspection March 2022
  • ANVISA · Identifier: project specific inspection 2021
  • MHRA · Identifier: cGMP inspection June 2021
  • FDA · Identifier: cGMP inspection May 2018
  • MHRA · Identifier: cGMP inspection April 2023
  • FDA · Identifier: Registered as bulk API manufacturer
  • DEA · Identifier: Approved to import, store, manufacture and export Schedule I-V controlled substances
  • FDA · Identifier: cGMP inspection March 2024
  • cGMP · Identifier: cGMP accreditation

Find similar companies

Quotient Sciences alternatives · Sterling Pharma Solutions alternatives

Markdown mirror: /compare/quotientsciences/sterlingpharmasolutions.md